Join
Live feed
·
INSIDERFilingvia Quantisnow
Cara Therapeutics Inc. logo

SEC Form 4: Posner Christopher sold $13,222 worth of shares (4,307 units at $3.07), decreasing direct ownership by 2% to 168,207 units

ByQuantisnow·Wall Street's wire, on your screen.
CARA· Cara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARA (Cara Therapeutics Inc.) and more on Quantisnow.